Metformin has been around since the 1950s, is prescribed to hundreds of millions of people worldwide, and costs about four dollars a month at most pharmacies. It is also one of the medications our patients have the most questions about — not because it is complicated, but because there is a lot of misinformation floating around about what it does and does not do. Let us clear it up.
What metformin actually does
Most people are surprised to learn that metformin's primary action is not about insulin. Its main job is to reduce the amount of glucose your liver produces and releases into the bloodstream overnight and between meals. Your liver, when blood sugar regulation is off, tends to pour out more glucose than it should. Metformin dials that back.
Beyond the liver, metformin also improves insulin sensitivity in muscle and fat tissue — meaning your body's own insulin works more effectively. And it modestly reduces how much glucose your gut absorbs from the food you eat.
A few things metformin does NOT do that people often worry about:
- It does not cause hypoglycemia on its own. Because metformin does not stimulate insulin release, low blood sugar is not a risk when you take it alone. This is one of its biggest safety advantages over some other diabetes medications.
- It does not cause weight gain. In fact, most patients either stay weight-neutral or lose a modest amount of weight on metformin. It is one of the few diabetes medications that does not work against weight management goals.
What metformin is used for
Type 2 diabetes is the primary use, and metformin is the recommended first-line medication by virtually every major diabetes guideline worldwide. Decades of evidence — including the landmark UK Prospective Diabetes Study — show it reduces A1C reliably, has a strong cardiovascular safety record, and is associated with meaningful long-term outcomes.
Prediabetes — when fasting glucose or A1C is elevated but not yet in the diabetes range. For patients at high risk of progressing to Type 2 diabetes, the Diabetes Prevention Program showed that metformin reduced that progression by about 31%. We discuss this option with patients whose risk profile warrants it.
PCOS (polycystic ovary syndrome) — insulin resistance is central to PCOS even in patients who are not overweight, and metformin is widely used to improve that insulin resistance. It can help with menstrual cycle regularity, ovarian function, and sometimes fertility. It is one of the medications we use most in our hormone-balance patients.
Gestational diabetes — in selected cases, metformin is used as an alternative to insulin, though this is an ongoing area of clinical discussion and we individualize the decision.
A few off-label uses are sometimes discussed — non-alcoholic fatty liver disease, and longevity research in the context of the TAME trial. These are premature for clinical recommendation and we mention them only because patients sometimes ask. We do not routinely prescribe metformin for these purposes outside of standard diabetes and prediabetes indications.
Forms and dosing — how we usually start
Metformin comes in two main forms:
Immediate-release (IR): Standard 500 mg tablets taken with meals. Available as generics everywhere. Typically dosed two to three times daily.
Extended-release (ER / XR / SR): 500 mg, 750 mg, and 1000 mg tablets, taken once or twice daily. These release metformin more slowly, which significantly reduces gastrointestinal side effects for many patients. This is often the form we reach for when tolerability is a concern.
A typical adult therapeutic dose is 1000 mg twice daily (2000 mg/day), though the maximum is 2550 mg/day. We never start there.
The starting approach that works best: 500 mg once daily with dinner for the first week. Then 500 mg with breakfast and dinner. Then up to 1000 mg twice daily over the following weeks. This slow escalation is the single most effective thing you can do to minimize GI side effects. Patients who start at a full therapeutic dose right away are the ones who have the worst time.
The GI side effects — honesty hour
We are going to be direct with you, because this is the number-one reason patients stop metformin before giving it a fair chance.
The most common side effects are gastrointestinal: diarrhea, gas, bloating, nausea, and sometimes a metallic taste. Roughly 20–30% of patients have meaningful GI symptoms when they start. These side effects are real and we do not minimize them.
Here is the important part: for most patients, these fade significantly after 2–4 weeks at a stable dose. The gut adapts. Patients who push through the first month at a consistent dose are usually glad they did.
Things that help:
- Take metformin with food — every time, without exception
- Switch to the ER form (it is specifically designed to be gentler on the GI tract and often makes a dramatic difference)
- Slow the dose escalation down — weeks, not days, between increases
- Avoid taking it on an empty stomach or with alcohol
About 5–10% of patients genuinely cannot tolerate metformin even with all of these strategies. That is okay. We have other options — GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors — and we will find what works for you without making you suffer through a medication that is clearly not fitting your gut.
B12 deficiency — the underappreciated long-term risk
This one gets missed more than it should.
Long-term metformin use — we are talking years — can reduce the absorption of vitamin B12 from the gut by interfering with a protein called intrinsic factor. The effect is gradual and often subtle. Symptoms of B12 deficiency can include fatigue, brain fog, and tingling or numbness in the feet. These symptoms overlap significantly with diabetic neuropathy, which means B12 deficiency can be mistaken for worsening nerve damage rather than a correctable nutritional problem.
At EPC, we check B12 levels annually in patients who have been on metformin for more than a year. If your level is low or trending down, we supplement — usually with sublingual B12 (which absorbs well even with impaired gut uptake) or occasionally with injections. This is a straightforward fix once we know to look for it.
If you have been on metformin for years and your B12 has never been checked, bring it up at your next visit.
Lactic acidosis — the scary warning that needs context
Metformin carries a black-box warning about lactic acidosis — a rare but serious buildup of lactic acid in the blood. This warning has made patients and some physicians unnecessarily cautious about using it.
The honest picture: lactic acidosis from metformin is extremely rare in patients with normal kidney function, estimated at fewer than 10 cases per 100,000 patient-years. It is largely a theoretical concern for most of our patients. The original fears about this risk were based on experience with a related drug (phenformin) that was far more problematic.
That said, there are specific situations where we hold metformin temporarily:
- Acute illness with significant vomiting or diarrhea — dehydration can impair kidney function, and the combination is where real risk enters
- Severe infection — same concern about acute kidney stress
- Major surgery or procedures requiring general anesthesia — standard practice is to hold metformin the morning of the procedure
- IV contrast for CT scans — we hold metformin for 48 hours before and after contrast-enhanced imaging and confirm kidney function is stable before restarting
These are sensible precautions, not reasons to fear the medication in everyday life.
Kidney function and the current guidelines
The old rule — contraindicated in any kidney impairment — has been revised based on better evidence.
Current guidelines are:
- eGFR 45 or above: Full-dose metformin is safe and appropriate
- eGFR 30–44: Metformin can continue but we reassess the dose and monitor more carefully
- eGFR below 30: Discontinue metformin
We check kidney function as part of standard diabetes monitoring — typically at least once a year, more often if there is any reason for concern. You do not need to track this yourself; we track it with you.
Drug interactions worth knowing
- IV contrast: As noted above — hold 48 hours before and after, confirm stable kidney function before restarting
- Topiramate (Topamax): Used for migraines and sometimes seizures; the combination can slightly increase lactic acidosis risk, which we factor in when both medications are appropriate
- Some HIV medications and certain antibiotics: Discuss with us whenever a new medication is added — we will flag anything that warrants attention
Metformin alongside GLP-1 medications
This combination is extremely common and very effective.
The typical approach: start metformin first, get to a therapeutic dose, check A1C at three months. If A1C is still not at target, that is when we consider adding a GLP-1 receptor agonist (Ozempic, Mounjaro, etc.). The two work through different mechanisms and complement each other well.
Once a patient is well-established on a GLP-1 at a good dose and their glucose control is strong, we sometimes reduce the metformin — particularly if the patient is experiencing more GI symptoms than we would like. We make that call together based on your labs and how you are feeling, not a protocol.
PCOS-specific notes
For PCOS, metformin doses are similar to diabetes doses — typically working up to 1000–1500 mg/day. The same GI considerations apply, and the same slow titration approach works here too.
What can improve with metformin in PCOS:
- Menstrual cycle regularity — often within 3–6 months
- Ovarian function and, in some patients, fertility outcomes
- Androgen levels (testosterone, DHEAS) — metformin can modestly lower these, which sometimes helps with acne and hirsutism
If you are on metformin and planning pregnancy, the decision about continuing during pregnancy is one we discuss individually. Current evidence generally supports continuation in many patients, but it depends on your specific situation and we want to walk through it with you before conception rather than after.
What to expect when you start: a timeline
Weeks 1–2: You are still titrating up. This is the window where GI side effects are most noticeable. Do not judge the medication on these first two weeks.
Weeks 4–6: At a stable dose, the GI symptoms typically settle. You may start to see slightly lower readings on your fingersticks or CGM — metformin's effect on fasting glucose can be noticeable within weeks.
3 months: First repeat A1C. At a therapeutic dose, most patients see a reduction of 1 to 1.5 percentage points. This is meaningful — enough to move many patients from poorly controlled into better range, or to avoid adding a second medication.
6–12 months: Stable maintenance dose. This is also when we start tracking B12 annually in patients who have been on it long-term.
What if you truly cannot tolerate it?
First: try the ER form if you have not. The switch from immediate-release to extended-release reduces or eliminates GI symptoms in a meaningful proportion of patients who had trouble with IR.
Second: slow the titration. Some patients need months, not weeks, to work up to a full dose.
If neither helps, we move on. No medication is worth suffering through. We have a growing toolkit — GLP-1 agonists, SGLT2 inhibitors, DPP-4 inhibitors — and we will find a regimen that your body tolerates and that does the job.
Cost: one of metformin's biggest advantages
Generic metformin is approximately $4 per month at most major pharmacies. It is one of the cheapest effective medications in all of modern medicine. Extended-release is sometimes a few dollars more, and it is covered by virtually every insurance plan.
If you are paying more than this for plain generic metformin, something is wrong — talk to your pharmacy.
Questions about metformin? Come see us.
We prescribe, adjust, and troubleshoot metformin every single day — for Type 2 diabetes, prediabetes, and PCOS. Whether you are just starting, wondering about a side effect that has been bothering you, or trying to decide whether metformin is still the right fit alongside a newer medication, these are exactly the conversations we have in clinic.
Request an appointment at our Houston or Katy office, or message us through the patient portal. We are glad to help you get the most out of this medication — or figure out a better path if it is not working for you.